ABOUT US MANAGEMENT TEAM

Dr. Tennenbaum is an acknowledged specialist in skin physiology and pathology, gene therapy and PKC signaling. She is the laureate of prestigious awards and grants including the Rothschild fellowship award, Fulbright award, ISF, GIF, ICRF and DKFZ grants and the J&J focus-funding program. Dr. Tennenbaum is the author of over 50 articles in peer review journals in skin research. Dr. Tennenbaum holds an MD from the Hebrew University Hadassah Medical School, Jerusalem, Israel, and a Ph.D in pharmacology and cell biology from the Hebrew University, Jerusalem, Israel.

Dr. Braiman received her PhD in biochemistry and cellular biology from the Faculty of Life Sciences, Bar Ilan University, Israel. Dr. Braiman has vast experience in biochemistry, cellular biology and molecular biology. Previously, Dr. Braiman was the Head of the Molecular and Functional Unit of the diabetes project at QBI Inc. Dr. Braiman heads HealOr's research and development.

Dr. Braude received his MD from the Sackler Faculty of Medicine, Tel-Aviv University, Israel. Prior to joining HealOr, Dr. Braude has held various positions in the pharma and biotech industry including: Teva Pharmaceuticals, Janssen-Cilag, Israel, Optonol Ltd and Optimata Ltd. Dr. Braude has extensive experience in product development, clinical trials and regulatory affairs.

Dr. Levy-Hacham received her PhD from Faculty of Chemistry, Israel Institute of Technology (Technion), Haifa. During her PhD studies she developed novel defibrilatory and antifibrilatory drugs. Before joining HealOr, Dr. Levy-Hacham has served as head of drug discovery in Proteologics Ltd. and prior to that she was a project manager of the anticancer project at Insight Ltd. Dr. Levy-Hacham brings to HealOr vast experience in drug discovery methods, development of novel formulations and manufacturing control.

Dr. Sagiv received his PhD from the department of biological chemistry, The Weizmann Institute of Science, Israel. Dr. Sagiv has served as a post-doctoral scholar at the University of Chicago, IL, USA, studying the mechanisms of lipid presentation to the immune system and their effect on Th1/Th2 immunological responses. Before joining HealOr, Dr. Sagiv has served as the head of research in Target-In Ltd. Dr. Sagiv brings to HealOr vast experience in the fields of immunology, biochemistry, molecular biology and animal model development.

Mr. Bar Zik brings to HealOr more than 18 years of executive management experience, primarily in the Hi-Tech sector. Mr. Bar Zik was with A.B. Data for more than twelve years serving as CFO and later as CEO. Most recently Mr. Bar Zik was CFO of Xor Technologies.

Mrs. Mandil-Levin brings to HealOr an extensive experience in business development and strategic alliances in the field of biotech startups. She was formerly business development manager at Proteologics Ltd. Mrs. Mandil-Levin holds a MSc in biochemistry from Bar-Ilan University and an MBA form the Israeli College of Management- Technology Company Management Program.